Cargando…

Animal models of Multiple Sclerosis

Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) which involves a complex interaction between immune system and neural cells. Animal modeling has been critical for addressing MS pathogenesis. The three most characterized animal models of MS are (1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Procaccini, Claudio, De Rosa, Veronica, Pucino, Valentina, Formisano, Luigi, Matarese, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094661/ https://www.ncbi.nlm.nih.gov/pubmed/25823807 http://dx.doi.org/10.1016/j.ejphar.2015.03.042

Ejemplares similares

Neuro-Endocrine Networks Controlling Immune System in Health and Disease
por: Procaccini, Claudio, et al.
Publicado: (2014)

Leptin modulates autophagy in human CD4(+)CD25(−) conventional T cells
por: Cassano, Silvana, et al.
Publicado: (2014)

Role of Adipokines Signaling in the Modulation of T Cells Function
por: Procaccini, Claudio, et al.
Publicado: (2013)

Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
por: Malfitano, Anna Maria, et al.
Publicado: (2013)

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis
por: Sambucci, Manolo, et al.
Publicado: (2018)

Polychlorinated Biphenyls Induce Mitochondrial Dysfunction in SH-SY5Y Neuroblastoma Cells
por: Cocco, Stefania, et al.
Publicado: (2015)

CD4(+) T-Cell Activation Prompts Suppressive Function by Extracellular Vesicle-Associated MicroRNAs
por: Di Silvestre, Dario, et al.
Publicado: (2021)

Animal Models of Multiple Sclerosis
por: Young, Colin R., et al.
Publicado: (2008)

Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis
por: Buttigieg, Emeline, et al.
Publicado: (2023)

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
por: Birmpili, Dafni, et al.
Publicado: (2022)

Animal models of multiple sclerosis—Potentials and limitations
por: Mix, Eilhard, et al.
Publicado: (2010)

The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
por: Segal, Benjamin M.
Publicado: (2019)

Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models
por: Zhan, Jiangshan, et al.
Publicado: (2021)

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
por: Raghib, Muhammad Faraz, et al.
Publicado: (2023)

Lactate: Fueling the fire starter
por: Certo, Michelangelo, et al.
Publicado: (2019)

Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis
por: Zha, Zheng, et al.
Publicado: (2022)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models
por: Weerasinghe-Mudiyanselage, Poornima D. E., et al.
Publicado: (2023)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
por: Plastini, Melanie J., et al.
Publicado: (2020)

Effectiveness of exercise interventions in animal models of multiple sclerosis
por: Parnow, Abdolhossein, et al.
Publicado: (2023)

MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
por: De Vito, Francesca, et al.
Publicado: (2021)

Meta-Immunological Profiling of Children With Type 1 Diabetes Identifies New Biomarkers to Monitor Disease Progression
por: Galgani, Mario, et al.
Publicado: (2013)

Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models
por: Nathoo, Nabeela, et al.
Publicado: (2014)

Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications
por: Cheng, Yun, et al.
Publicado: (2017)

Editorial: Animal models of multiple sclerosis: can they advance future therapies?
por: DeSilva, Tara Maria, et al.
Publicado: (2023)

Animal models of systemic sclerosis: their utility and limitations
por: Artlett, Carol M
Publicado: (2014)

Fatty acids - from energy substrates to key regulators of cell survival, proliferation and effector function
por: Cucchi, Danilo, et al.
Publicado: (2019)

Animal models of multiple sclerosis: the good, the bad and the bottom line
por: Ransohoff, Richard M
Publicado: (2012)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
por: das Neves, Sofia Pereira, et al.
Publicado: (2023)

Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells
por: Vitale, Nicoletta, et al.
Publicado: (2013)

Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019
por: Martinez, Bridget, et al.
Publicado: (2020)

Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review
por: Blais, Lorrie L., et al.
Publicado: (2021)

Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration
por: La Rocca, Claudia, et al.
Publicado: (2017)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

Smouldering multiple sclerosis: the ‘real MS’
por: Giovannoni, Gavin, et al.
Publicado: (2022)

IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism
por: Vigo, Tiziana, et al.
Publicado: (2019)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
por: Azzolini, Federica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dbml9itb947j21d67ourh2mg5l